JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/65/0.1/21.06.24 | Delayed Börse Stuttgart 08:26:48 12/06/2024 BST | ||
| 0.001 EUR | -80.00% |
|
| 3 months | -96.30% | ||
| 6 months | -97.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 12/06/24 | 0.001 | -80.00% |
| 11/06/24 | 0.005 | +400.00% |
Delayed Quote Börse Stuttgart
Last update June 12, 2024 at 08:26 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | J.P. Morgan |
| WKN | JS9CYS |
| ISIN | DE000JS9CYS7 |
| Date issued | 14/03/2023 |
| Strike | 65 $ |
| Maturity | 21/06/2024 (1 Days) |
| Parity | 10 : 1 |
| Emission price | 0.76 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1 € |
|---|---|
| Lowest since issue | 0.001 € |
| Spread | 0.01 € |
| Spread % | 90.91% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.81
USD
Average target price
53.19
USD
Spread / Average Target
+30.35%
- Stock Market
- Warrants
- Warrant
